VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
VM Oncology, LLC
National Institutes of Health Clinical Center (CC)
Incyte Corporation
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Incyte Corporation
A2 Biotherapeutics Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
University College, London
Alliance for Clinical Trials in Oncology
Sotio Biotech Inc.
Travera Inc
University of Leeds
Kyowa Kirin Co., Ltd.
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Translational Research in Oncology
Jules Bordet Institute
Xencor, Inc.
Incyte Corporation
Rijnstate Hospital
AbbVie
AbbVie
Massachusetts General Hospital
Incyte Corporation
Incyte Corporation
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Swiss Cancer Institute
Wake Forest University Health Sciences
Stanford University
National Cancer Institute (NCI)
Novartis
Pierian Biosciences
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)